A Chimeric SERM–Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1860-7187|9|3|602-613

ISSN： 1860-7179

Source： CHEMMEDCHEM, Vol.9, Iss.3, 2014-03, pp. : 602-613

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cover Picture: A Chimeric SERM–Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy (ChemMedChem 3/2014)

By  

CHEMMEDCHEM, Vol. 9, Iss. 3, 2014-03 ,pp. : 413-413

John Wiley & Sons Inc

Access to resources Recommend Favorite

Natural Products as Zinc‐Dependent Histone Deacetylase Inhibitors

By  

CHEMMEDCHEM, Vol. 10, Iss. 3, 2015-03 ,pp. : 441-450

John Wiley & Sons Inc

Access to resources Recommend Favorite

Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy

By  

CHEMISTRY - A EUROPEAN JOURNAL, Vol. 21, Iss. 46, 2015-11 ,pp. : 16517-16524

John Wiley & Sons Inc

Access to resources Recommend Favorite

Restoring Histone Deacetylase Activity by Waste Product Release. A View from Molecular Mechanics Simulations with Mammalian HDAC8

By  

CHEMISTRY & BIODIVERSITY, Vol. 12, Iss. 4, 2015-04 ,pp. : 503-512

John Wiley & Sons Inc

Access to resources Recommend Favorite

Design, Synthesis, and Biological Activity of NCC149 Derivatives as Histone Deacetylase 8‐Selective Inhibitors

By  

CHEMMEDCHEM, Vol. 9, Iss. 3, 2014-03 ,pp. : 657-664

John Wiley & Sons Inc

Access to resources Recommend Favorite